Core Viewpoint - The company has announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 1 yuan (including tax) for every 10 shares, with no bonus shares or capital reserve transfers [1][2][3]. Group 1: Board and Supervisory Committee Review - The board of directors has unanimously approved the profit distribution plan, stating it aligns with the company's actual situation and benefits long-term development and investor interests [1][2]. - The supervisory committee also agrees with the plan, emphasizing its compliance with relevant laws and regulations while balancing the company's financial status and future funding needs [2]. Group 2: Profit Distribution Plan Details - The profit distribution plan is based on the company's strong and stable profitability, with a net profit of 115,118,078.10 yuan for the first half of 2025 and a total distributable profit of 650,157,687.80 yuan [2][3]. - The total cash dividend amount proposed is 52,223,752.50 yuan (including tax) [3]. Group 3: Justification for Cash Dividend - The cash dividend plan complies with various legal and regulatory frameworks, ensuring the company's normal operations and long-term development while considering shareholder interests [3][4].
三鑫医疗: 关于2025年中期利润分配预案的公告